158 related articles for article (PubMed ID: 37958675)
1. Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation.
Baldan-Martin M; Rubín de Célix C; Orejudo M; Ortega Moreno L; Fernández-Tomé S; Soleto I; Ramirez C; Arroyo R; Fernández P; Santander C; Moreno-Monteagudo JA; Casanova MJ; Casals F; Casabona S; Becerro I; Lozano JJ; Aransay AM; Chaparro M; Gisbert JP
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958675
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Antisense Noncoding RNA in the INK4 Locus Correlates With Risk, Severity, Inflammation and Infliximab Efficacy in Crohn's Disease.
Ge Q; Dong Y; Lin G; Cao Y
Am J Med Sci; 2019 Feb; 357(2):134-142. PubMed ID: 30665494
[TBL] [Abstract][Full Text] [Related]
3. Expression alteration of long non-coding RNAs and their target genes in the intestinal mucosa of patients with Crohn's disease.
Li N; Shi R
Clin Chim Acta; 2019 Jul; 494():14-21. PubMed ID: 30862513
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT
Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs associated with ileal and colonic Crohn's disease.
Wu F; Zhang S; Dassopoulos T; Harris ML; Bayless TM; Meltzer SJ; Brant SR; Kwon JH
Inflamm Bowel Dis; 2010 Oct; 16(10):1729-38. PubMed ID: 20848482
[TBL] [Abstract][Full Text] [Related]
7. Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.
Noble CL; Abbas AR; Lees CW; Cornelius J; Toy K; Modrusan Z; Clark HF; Arnott ID; Penman ID; Satsangi J; Diehl L
Inflamm Bowel Dis; 2010 Oct; 16(10):1717-28. PubMed ID: 20848455
[TBL] [Abstract][Full Text] [Related]
8. Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects.
Mohammadi A; Kelly OB; Smith MI; Kabakchiev B; Silverberg MS
J Crohns Colitis; 2019 Oct; 13(11):1459-1469. PubMed ID: 31001642
[TBL] [Abstract][Full Text] [Related]
9. Role of the advanced glycation end products receptor in Crohn's disease inflammation.
Ciccocioppo R; Vanoli A; Klersy C; Imbesi V; Boccaccio V; Manca R; Betti E; Cangemi GC; Strada E; Besio R; Rossi A; Falcone C; Ardizzone S; Fociani P; Danelli P; Corazza GR
World J Gastroenterol; 2013 Dec; 19(45):8269-81. PubMed ID: 24363518
[TBL] [Abstract][Full Text] [Related]
10. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.
Ricciardelli I; Lindley KJ; Londei M; Quaratino S
Immunology; 2008 Oct; 125(2):178-83. PubMed ID: 18422560
[TBL] [Abstract][Full Text] [Related]
11. [Mucosal healing in different intestinal segments in patients receiving infliximab treatment for small bowel Crohn's disease].
Zhu ZH; Qiu C; Zhang M; Chen Z; Xiang C; Wang XY
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):44-48. PubMed ID: 28109097
[TBL] [Abstract][Full Text] [Related]
12. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
[TBL] [Abstract][Full Text] [Related]
13. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
14. Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
Haberman Y; BenShoshan M; Di Segni A; Dexheimer PJ; Braun T; Weiss B; Walters TD; Baldassano RN; Noe JD; Markowitz J; Rosh J; Heyman MB; Griffiths AM; Crandall WV; Mack DR; Baker SS; Kellermayer R; Patel A; Otley A; Steiner SJ; Gulati AS; Guthery SL; LeLeiko N; Moulton D; Kirschner BS; Snapper S; Avivi C; Barshack I; Oliva-Hemker M; Cohen SA; Keljo DJ; Ziring D; Anikster Y; Aronow B; Hyams JS; Kugathasan S; Denson LA
Inflamm Bowel Dis; 2018 Jan; 24(2):346-360. PubMed ID: 29361088
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-α Biologics Do Not Reverse CDX2 Downregulation in Patients with Crohn's Disease.
Younes M; Rahimi E; DuPont AW; Ly CJ; Ertan A
Ann Clin Lab Sci; 2020 Mar; 50(2):172-174. PubMed ID: 32366553
[TBL] [Abstract][Full Text] [Related]
16. Natural history of children with mild Crohn's disease.
Sharma Y; Bousvaros A; Liu E; Bender Stern J
World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
[TBL] [Abstract][Full Text] [Related]
17. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease.
Narula N; Wong ECL; Dulai PS; Marshall JK; Jairath V; Reinisch W
Am J Gastroenterol; 2022 Jul; 117(7):1106-1117. PubMed ID: 35435862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
